Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • VRT vs MRNA✓SelectedUSD · MRNAVRT vs MRNA performance historyLatest closeAs of-10.14%11/20
Stock and ETF performance explorer

VRT vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+4.3%
MRNA return
+697.5%
Excess return
-693.3%
Maximum drawdown
-55.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-10.1%-2.2%-8.0%-10.1%
7D-17.7%-12.7%-5.0%-17.7%
30D-21.6%-20.7%-1.0%-21.6%
3M-37.2%+46.3%-83.4%-36.8%
6M-47.3%+305.2%-352.6%-49.3%
YTD+2.7%+561.2%-558.6%-12.3%
1Y+4.3%+772.1%-767.8%-21.4%
All+4.3%+697.5%-693.3%-21.4%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling